Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lusedra Dosing for Colonoscopy Sedation in Special Populations
NCT01127438Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Apr 2010
- Primary completion
- Jun 2011
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of phospropofol disodium in Procedural sedation (PS) (6 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Number of Participants With Sedation Success at Day 1. Started Apr 2010; status: completed.
02
Drugs
phospropofol disodium
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT01127438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01127438.